Anna Nadali

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family

Carole J. R. Bataille, Méabh B. Brennan, Simon Byrne et al. · Bioorganic & Medicinal Chemistry · 2017 · 45 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +12

Detection of sites of infection in mice using 99mTc-labeled PN2S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study

Laura Meléndez‐Alafort, Anna Nadali, Gianfranco Pasut et al. · Nuclear Medicine and Biology · 2009 · 43 citations

Laboratory Immunology, Immunology, 99Mtc-labeled Pn2s-peg +5

Biodistribution imaging of a paclitaxel-hyaluronan bioconjugate

Alessandra Banzato, Maria Rondina, Laura Meléndez‐Alafort et al. · Nuclear Medicine and Biology · 2009 · 23 citations

Tissue Imaging, Engineering, Biomedical Imaging +6

Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma

Laura Meléndez‐Alafort, Anna Nadali, Elena Zangoni et al. · Nuclear Medicine and Biology · 2009 · 21 citations

188Re-hyaluronic Acid, Surgical Oncology, Oncology +13

Bioavailability of ^99mTc‐Ha‐paclitaxel complex [^99mTc‐ONCOFID‐P] in mice using four different administration routes

Laura Meléndez‐Alafort, Mattia Riondato, Anna Nadali et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2006 · 18 citations

Nanotherapeutics, Pharmacotherapy, Experimental Pharmacology +17